Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

Sufentanil 1((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gynecological Laparoscopic Surgery × 1 year × Clear all
NCT07372209 2026-01-28

Effects and Safety of Oliceridine in Anesthesia Induction:A Randomised Controlled Trial

Tangshan Maternal and Child Health Hospital

Phase NA Completed
120 enrolled

Gynecological Laparoscopic Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡